本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Axsome Therapeutics, Inc.

121.28
-0.4700-0.39%
盘后121.280.00000.00%16:39 EDT
成交量:35.17万
成交额:4,263.58万
市值:60.52亿
市盈率:-23.95
高:122.28
开:121.75
低:119.93
收:121.75
52周最高:139.13
52周最低:75.56
股本:4,990.15万
流通股本:4,187.28万
量比:0.59
换手率:0.84%
股息:- -
股息率:- -
每股收益(TTM):-5.0644
每股收益(LYR):-5.9944
净资产收益率:-280.68%
总资产收益率:-21.90%
市净率:82.82
市盈率(LYR):-20.23

数据加载中...

2025/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

重要事件披露

Form 8-K - Current report
2025/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/10

重要事件披露

Form 8-K - Current report
2025/06/10

重要事件披露

Form 8-K - Current report
2025/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/09

重要事件披露

Form 8-K - Current report
2025/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities